tiprankstipranks
Advertisement
Advertisement
MediWound Earnings Call Balances Setbacks and Expansion
PremiumCompany AnnouncementsMediWound Earnings Call Balances Setbacks and Expansion
26d ago
MediWound: BARDA Contract Reinstatement, Capacity Expansion, and EscharEx Pipeline Catalysts Support Long-Term Buy Thesis
Premium
Ratings
MediWound: BARDA Contract Reinstatement, Capacity Expansion, and EscharEx Pipeline Catalysts Support Long-Term Buy Thesis
29d ago
Buy Rating Backed by Temporary Q4 Disruption, Long-Term Government Contracts, and NexoBrid-Driven Growth
Premium
Ratings
Buy Rating Backed by Temporary Q4 Disruption, Long-Term Government Contracts, and NexoBrid-Driven Growth
29d ago
MediWound management to meet with Maxim
PremiumThe FlyMediWound management to meet with Maxim
1M ago
Is MDWD a Buy, Before Earnings?
Premium
Pre-Earnings
Is MDWD a Buy, Before Earnings?
1M ago
MediWound Shareholders Approve Expansion of 2024 Equity Incentive Pool
Premium
Company Announcements
MediWound Shareholders Approve Expansion of 2024 Equity Incentive Pool
1M ago
MediWound sees FY26 revenue $24-26M, consensus $28.8M
PremiumThe FlyMediWound sees FY26 revenue $24-26M, consensus $28.8M
3M ago
MediWound reports clinical data on NexoBrid’s effectiveness
Premium
The Fly
MediWound reports clinical data on NexoBrid’s effectiveness
4M ago
MediWound: Strong Financial Health and Market Opportunities Drive Buy Rating
Premium
Ratings
MediWound: Strong Financial Health and Market Opportunities Drive Buy Rating
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100